Efficacy and Tolerance of Single-Dose Azithromycin for Treatment of Chlamydial Cervicitis During Pregnancy
1995

Efficacy of Single-Dose Azithromycin for Chlamydia in Pregnant Women

Sample size: 146 publication Evidence: moderate

Author Information

Author(s): Joseph M. Miller, Jr.

Primary Institution: Louisiana State University Medical Center

Hypothesis

Is a single-dose oral azithromycin effective and well tolerated for treating chlamydial cervicitis in pregnant women?

Conclusion

A single 1-g oral dose of azithromycin is effective for the treatment of chlamydia and is well tolerated in pregnant women.

Supporting Evidence

  • A cure rate of 96% was found among the treated patients.
  • Only 5% of patients reported side effects.
  • Azithromycin was better tolerated than erythromycin in previous studies.

Takeaway

This study found that giving pregnant women one dose of azithromycin can help them get rid of chlamydia, and most women didn't feel sick from the medicine.

Methodology

A retrospective review of clinic records over a two-year period identified pregnant patients treated with a single 1-g dose of azithromycin for chlamydial carriage.

Potential Biases

The study population was primarily young Afro-Americans, which may not represent all demographics.

Limitations

The study relied on patient recall for side effects and did not keep diaries.

Participant Demographics

The majority were young Afro-American women, with ages ranging from under 15 to over 30.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication